- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Global Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
UPDATED Apr 08, 2024
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
44 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
A000020 | ₩8,930.00 | -6.0% | 4.9% | ₩247.5b | n/a | PE9x | n/a | 2.0% | ||
1061 | HK$2.26 | -3.8% | -40.2% | HK$1.3b | HK$5.12 | PE4.7x | E28.7% | 4.0% | ||
A016580 | ₩14,320.00 | -1.9% | -12.8% | ₩218.6b | ₩21,000.00 | PE7.3x | E1.1% | 2.1% | ||
531633 | ₹608.15 | 1.6% | 62.1% | ₹12.2b | n/a | PE14x | n/a | 0.2% | ||
2633 | HK$0.57 | -3.4% | -39.4% | HK$1.1b | n/a | PE4.7x | n/a | 8.6% | ||
503 | HK$1.79 | 0% | 23.6% | HK$750.6m | n/a | PE13x | n/a | 2.7% | ||
VLS | AU$2.28 | -5.8% | 60.6% | AU$129.8m | n/a | PE14.3x | n/a | 3.9% | ||
A106190 | ₩9,740.00 | -2.6% | 11.2% | ₩103.6b | n/a | PE12.8x | n/a | 1.0% | ||
6817 | NT$127.00 | -2.7% | 59.9% | NT$2.3b | n/a | PE14.7x | n/a | 5.2% | ||
MAB | zł16.58 | 1.7% | -9.6% | zł268.0m | zł15.57 | PE4.6x | E-15.5% | n/a | ||
A359090 | ₩1,446.00 | 17.3% | 27.9% | ₩79.4b | n/a | PE14.3x | n/a | n/a | ||
EURO | ₱0.76 | -3.8% | -13.6% | ₱3.1b | n/a | PE12.2x | n/a | 4.6% | ||
A238120 | ₩4,470.00 | -2.0% | 2.8% | ₩64.3b | n/a | PE19.9x | n/a | n/a | ||
OCPH | ج.م100.00 | 0% | 0% | ج.م1.2b | n/a | PE8x | n/a | 0% | ||
532384 | ₹201.75 | 11.5% | 32.5% | ₹2.1b | n/a | PE14.5x | n/a | 1.0% | ||
AXPH | ج.م226.00 | -2.6% | 67.4% | ج.م1.2b | n/a | PE7.5x | n/a | 5.8% | ||
EZZ | AU$0.73 | 26.7% | 77.1% | AU$31.4m | AU$1.46 | PE9x | S11.9% | 1.3% | ||
NIPH | ج.م81.83 | 0% | 106.4% | ج.م828.5m | n/a | PE8.8x | n/a | 6.1% | ||
BGD | zł26.00 | -2.3% | 89.8% | zł63.9m | n/a | PE15.2x | n/a | 1.5% | ||
CANB | CA$0.10 | -12.5% | -50.0% | CA$14.5m | n/a | PE4.4x | n/a | n/a |